Definition and research guide
This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.
Content available: 4 complete abstracts (751 words), 10 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.
Definition
An acute diarrheal disease endemic in India and Southeast Asia whose causative agent is vibrio cholerae. This condition can lead to severe dehydration in a matter of hours unless quickly treated.
Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.
Also known as: Choleras; Vibrio cholerae Infection; Infections, Vibrio cholerae; Infection, Vibrio cholerae; Vibrio cholerae Infections.
Where it fits in the MeSH classification
- Broader topics
- Vibrio Infections
- See also
- Cholera Morbus
Related concepts
- Vibrio Cholerae
Research landscape
PubMed indexes 9,873 records tagged with the MeSH heading “Cholera” (counts retrieved 2026-10-29). 1,244 of them (12.6%) were published from 2020 onward, and the busiest period so far is through 1999 with 5,186 records.
Reviews account for 847 records (8.6%) and meta-analyses for 40. Randomized controlled trials number 220 (2.2%) as a share of all records on the topic.
Show the data
| Period | Records |
|---|---|
| through 1999 | 5,186 |
| 2000-2009 | 1,353 |
| 2010-2019 | 2,090 |
| 2020 onward | 1,244 |
Publication-type chart data
| Type | Records | Share |
|---|---|---|
| Reviews | 847 | 8.6% |
| Meta-analyses | 40 | 0.4% |
| Randomized controlled trials | 220 | 2.2% |
Method: PubMed query "Cholera"[MeSH Terms] with publication-type and date filters, retrieved 2026-10-29.
Reading the evidence in infectious diseases
Infectious disease evidence combines microbiology, epidemiology and clinical trials. Laboratory studies identify pathogens and how they cause harm; surveillance and outbreak investigations describe who is affected and how infection spreads; trials establish whether treatments and vaccines work. Results depend on place and time, because pathogens evolve and resistance patterns and population immunity change. Check when and where the data were collected, how cases were defined and how up to date the evidence is.
Evidence from open-access studies
These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.
| Study / authors | Year | Source label / design | Europe PMC citations | Licence / source |
|---|---|---|---|---|
| Cholera outbreaks in sub-Saharan Africa during 2010-2019: a descriptive analysis | 2022 | Research article Design not recorded in structured metadata | 58 | cc by PMID 35605949 · DOI · PMC9439956 |
| Genomic epidemiology reveals multidrug resistant plasmid spread between Vibrio cholerae lineages in Yemen | 2023 | Research article Design not recorded in structured metadata | 51 | cc by PMID 37770747 · DOI · PMC10539172 |
| The Vibrio cholerae Seventh Pandemic Islands act in tandem to defend against a circulating phage | 2022 | Research article Design not recorded in structured metadata | 46 | cc by PMID 36026491 · DOI · PMC9455884 |
| Multicountry genomic analysis underscores regional cholera spread in Africa | 2026 | Research article Design not recorded in structured metadata | 10 | cc by PMID 41663395 · DOI · PMC13000271 |
Cholera outbreaks in sub-Saharan Africa during 2010-2019: a descriptive analysis [1]
Abstract reading summary — source excerpts
- Opening excerpt
- BackgroundCholera remains a public health threat but is inequitably distributed across sub-Saharan Africa.
- Closing excerpt
- ConclusionsThis study provides a baseline from which the progress toward cholera control and essential statistics to inform outbreak management in sub-Saharan Africa can be monitored.
- Interpretation limits
- Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (193 words)
BackgroundCholera remains a public health threat but is inequitably distributed across sub-Saharan Africa. Lack of standardized reporting and inconsistent outbreak definitions limit our understanding of cholera outbreak epidemiology.MethodsFrom a database of cholera incidence and mortality, we extracted data from sub-Saharan Africa and reconstructed outbreaks of suspected cholera starting in January 2010 to December 2019 based on location-specific average weekly incidence rate thresholds. We then described the distribution of key outbreak metrics.ResultsWe identified 999 suspected cholera outbreaks in 744 regions across 25 sub-Saharan African countries. The outbreak periods accounted for 1.8 billion person-months (2% of the total during this period) from January 2010 to January 2020. Among 692 outbreaks reported from second-level administrative units (e.g., districts), the median attack rate was 0.8 per 1000 people (interquartile range (IQR), 0.3-2.4 per 1000), the median epidemic duration was 13 weeks (IQR, 8-19), and the median early outbreak reproductive number was 1.8 (range, 1.1-3.5). Larger attack rates were associated with longer times to outbreak peak, longer epidemic durations, and lower case fatality risks.ConclusionsThis study provides a baseline from which the progress toward cholera control and essential statistics to inform outbreak management in sub-Saharan Africa can be monitored.
Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 35605949 · DOI · PMC9439956
Genomic epidemiology reveals multidrug resistant plasmid spread between Vibrio cholerae lineages in Yemen [2]
Abstract reading summary — source excerpts
- Opening excerpt
- Since 2016, Yemen has been experiencing the largest cholera outbreak in modern history.
- Closing excerpt
- Stable co-occurrence of the IncC plasmid with the SXT family of integrative and conjugative element in the 7PET background has major implications for cholera control, highlighting the importance of genomic epidemiological surveillance to limit MDR spread.
- Interpretation limits
- Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (154 words)
Since 2016, Yemen has been experiencing the largest cholera outbreak in modern history. Multidrug resistance (MDR) emerged among Vibrio cholerae isolates from cholera patients in 2018. Here, to characterize circulating genotypes, we analysed 260 isolates sampled in Yemen between 2018 and 2019. Eighty-four percent of V. cholerae isolates were serogroup O1 belonging to the seventh pandemic El Tor (7PET) lineage, sub-lineage T13, whereas 16% were non-toxigenic, from divergent non-7PET lineages. Treatment of severe cholera with macrolides between 2016 and 2019 coincided with the emergence and dominance of T13 subclones carrying an incompatibility type C (IncC) plasmid harbouring an MDR pseudo-compound transposon. MDR plasmid detection also in endemic non-7PET V. cholerae lineages suggested genetic exchange with 7PET epidemic strains. Stable co-occurrence of the IncC plasmid with the SXT family of integrative and conjugative element in the 7PET background has major implications for cholera control, highlighting the importance of genomic epidemiological surveillance to limit MDR spread.
Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 37770747 · DOI · PMC10539172
The Vibrio cholerae Seventh Pandemic Islands act in tandem to defend against a circulating phage [3]
Abstract reading summary — source excerpts
- Opening excerpt
- The current circulating pandemic El Tor biotype of Vibrio cholerae has persisted for over sixty years and is characterized by its acquisition of two unique genomic islands called the Vibrio Seventh Pandemic Islands 1 and 2 (VSP-I and VSP-II).
- Closing excerpt
- cholerae and highlights the key regulatory and mechanistic insights that can be gained by studying anti-phage systems in their native contexts.
- Interpretation limits
- Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (231 words)
The current circulating pandemic El Tor biotype of Vibrio cholerae has persisted for over sixty years and is characterized by its acquisition of two unique genomic islands called the Vibrio Seventh Pandemic Islands 1 and 2 (VSP-I and VSP-II). However, the functions of most of the genes on VSP-I and VSP-II are unknown and the advantages realized by El Tor through these two islands are not clear. Recent studies have broadly implicated these two mobile genetic elements with phage defense. Still, protection against phage infection through these islands has not been observed directly in any V. cholerae El Tor biotype. Here we report the isolation of a circulating phage from a cholera patient stool sample and demonstrate that propagation of this phage in its native host is inhibited by elements in both VSP-I and VSP-II, providing direct evidence for the role of these genomic islands in phage defense. Moreover, we show that these defense systems are regulated by quorum sensing and active only at certain cell densities. Finally, we have isolated a naturally occurring phage variant that is resistant to the defense conferred by the VSP islands, illustrating the countermeasures used by phages to evade these defense mechanisms. Together, this work demonstrates a functional role for the VSPs in V. cholerae and highlights the key regulatory and mechanistic insights that can be gained by studying anti-phage systems in their native contexts.
Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 36026491 · DOI · PMC9455884
Multicountry genomic analysis underscores regional cholera spread in Africa [4]
Abstract reading summary — source excerpts
- Opening excerpt
- Cholera remains a significant public health burden in many countries in sub-Saharan Africa, though the exact mechanisms of bacterial emergence and spread remain largely undefined.
- Closing excerpt
- Overall, our findings emphasize the importance of regionally coordinated cross-border surveillance and interventions, while also demonstrating the critical role of locally generated genomic data in understanding the spread of cholera in Africa.
- Interpretation limits
- Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (173 words)
Cholera remains a significant public health burden in many countries in sub-Saharan Africa, though the exact mechanisms of bacterial emergence and spread remain largely undefined. We generated genomic data from 763 Vibrio cholerae O1 isolates predominantly collected between 2019-2024 to create the largest dataset of V. cholerae genomes sequenced locally in Africa. This dataset enabled us to interrogate recent patterns of spread, including the rapid circulation of the AFR15 lineage associated with unusually large outbreaks in Southern Africa. We provide evidence for the movement of the AFR15 lineage into new African Union Member States and confirm previously observed differences in V. cholerae transmission dynamics in West versus East Africa, though cross-border transmission is prevalent on both sides of the continent. Despite observed differences, evolutionary processes are similar across lineages and we find no evidence for significant changes in antimicrobial resistance genotypes. Overall, our findings emphasize the importance of regionally coordinated cross-border surveillance and interventions, while also demonstrating the critical role of locally generated genomic data in understanding the spread of cholera in Africa.
Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 41663395 · DOI · PMC13000271
Key reviews and meta-analyses
The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.
References
- Zheng Q, Luquero FJ, Ciglenecki I, Wamala JF, Abubakar A, Welo P, et al.. Cholera outbreaks in sub-Saharan Africa during 2010-2019: a descriptive analysis. . 2022. PMID 35605949 · DOI · PMC9439956
- Lassalle F, Al-Shalali S, Al-Hakimi M, Njamkepo E, Bashir IM, Dorman MJ, et al.. Genomic epidemiology reveals multidrug resistant plasmid spread between Vibrio cholerae lineages in Yemen. . 2023. PMID 37770747 · DOI · PMC10539172
- O'Hara BJ, Alam M, Ng WL. The Vibrio cholerae Seventh Pandemic Islands act in tandem to defend against a circulating phage. . 2022. PMID 36026491 · DOI · PMC9455884
- Mboowa G, Matteson NL, Tanui CK, Kasonde M, Kamwiziku GK, Akanbi OA, et al.. Multicountry genomic analysis underscores regional cholera spread in Africa. . 2026. PMID 41663395 · DOI · PMC13000271
- Kaper JB, Morris JG, Levine MM. Cholera. Clin Microbiol Rev. 1995. PMID 7704895 · DOI · PMC172849
- Sack DA, Sack RB, Nair GB, Siddique AK. Cholera. Lancet. 2004. PMID 14738797 · DOI
- Faruque SM, Albert MJ, Mekalanos JJ. Epidemiology, genetics, and ecology of toxigenic Vibrio cholerae. Microbiol Mol Biol Rev. 1998. PMID 9841673 · DOI · PMC98947
- Harris JB, LaRocque RC, Qadri F, Ryan ET, Calderwood SB. Cholera. Lancet. 2012. PMID 22748592 · DOI · PMC3761070
- Clemens JD, Nair GB, Ahmed T, Qadri F, Holmgren J. Cholera. Lancet. 2017. PMID 28302312 · DOI
- Reidl J, Klose KE. Vibrio cholerae and cholera: out of the water and into the host. FEMS Microbiol Rev. 2002. PMID 12069878 · DOI
About this article
- Sources
- NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
- Verification
- Every reference was resolved against PubMed on 2026-10-31; title, year and DOI matched.
- Review state
- automated source verified; no human expert review has been recorded yet.
- Version
- 1, last updated 2026-10-29.
See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.
Evidence strength
EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.